The obesity treatment market has grown to break its own record for 3 consecutive years. The introduction of a new type of obesity treatment such as ‘Saxenda’ and ‘Qsymia’ had also led to market expansion.’ The two drugs have dominated the share of existing products and have occupied about half of the total market.

According to market research institution IQVIA on the 3rd, the obesity treatment market size recorded ₩143.6 billion last year, a 0.4% increase from the previous year.

The obesity treatment market has been breaking new records every year since 2019. Total sales in 2019 amounted to ₩134.1 billion won, up 38.6% from the previous year, and exceeded 100 billion won fo